Literature DB >> 3622432

The antibody response to methyl isocyanate: experimental and clinical findings.

M H Karol, S Taskar, S Gangal, B F Rubanoff, S R Kamat.   

Abstract

As a result of the industrial accident in Bhopal, India (December 1984) in which thousands of people were exposed to methyl isocyanate (MIC), concern was raised for possible long-term health effects. The well-recognized immunologic consequences of exposure to other industrial isocyanates prompted investigation of an antibody response to MIC. Using procedures which had been developed in this laboratory to evaluate isocyanate immunotoxicity, animal studies were undertaken to develop and test reagents which could be used to detect antibodies to MIC in the exposed population. Guinea pigs were injected with MIC in its reactive isocyanate form. Three weeks later, blood was drawn and serum evaluated using ELISA. To detect antibodies, an antigen was prepared by reaction of MIC with guinea pig serum albumin. Antibodies were detected in each of the four animals injected with MIC. Titers achieved were 1:5120 to 1:10,240. Inhibition assays revealed antibody specificity directed toward the MIC hapten. Analogous antigens prepared by reaction of MIC with human serum albumin were used to evaluate sera from individuals exposed in Bhopal to MIC. Antibodies were detected in 12 of 144 exposed persons. Antibodies were specific for MIC, as evidenced by inhibition assays, and belonged to the IgG, IgM and IgE classes. However, titers were generally low and transient and were found in persons having had the highest MIC exposures. Total IgE values of sera were not significantly different from those of control sera obtained from Bombay residents. The results indicate that exposure to methyl isocyanate resulted in production of specific antibodies. However, the low titers observed and the transient nature of the response suggest little health consequence should result form the antibody response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622432      PMCID: PMC1474631          DOI: 10.1289/ehp.8772169

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  20 in total

1.  Allergic contact dermatitis in polyurethane plastic moulders.

Authors:  E A Emmett
Journal:  J Occup Med       Date:  1976-12

2.  Hapten-specific respiratory hypersensitivity in guinea pigs.

Authors:  M H Karol; H H Ioset; E J Riley; Y C Alarie
Journal:  Am Ind Hyg Assoc J       Date:  1978-07

3.  Survey of industrial workers for antibodies to toluene diisocyanate.

Authors:  M H Karol
Journal:  J Occup Med       Date:  1981-11

4.  Occupational hypersensitivity pneumonitis after exposure to diphenylmethane diisocyanate.

Authors:  J L Malo; C R Zeiss
Journal:  Am Rev Respir Dis       Date:  1982-01

5.  Arachidonic acid's role in the pathology and physiology of pregnancy and labor.

Authors:  P L Ogburn; W E Brenner; J R Dingfelder; P P Williams; M I Siegel; S Maynard; S Johnson; R T Holman
Journal:  Prog Lipid Res       Date:  1981       Impact factor: 16.195

6.  [Intoxication due to dicyclohexyl-methane-4-4' diisocyanate exposure (author's transl)].

Authors:  R Israeli; V Smirnov; M Sculsky
Journal:  Int Arch Occup Environ Health       Date:  1981       Impact factor: 3.015

7.  Longitudinal study of tolyl-reactive IgE antibodies in workers hypersensitive to TDI.

Authors:  M H Karol; T Sandberg; E J Riley; Y Alarie
Journal:  J Occup Med       Date:  1979-05

8.  Study of guinea pig and human antibodies to toluene diisocyanate.

Authors:  M H Karol
Journal:  Am Rev Respir Dis       Date:  1980-12

9.  Hypersensitivity pneumonitis after exposure to isocyanates.

Authors:  J Charles; A Bernstein; B Jones; D J Jones; J H Edwards; R M Seal; A Seaton
Journal:  Thorax       Date:  1976-04       Impact factor: 9.139

10.  Dermal contact with toluene diisocyanate (TDI) produces respiratory tract hypersensitivity in guinea pigs.

Authors:  M H Karol; B A Hauth; E J Riley; C M Magreni
Journal:  Toxicol Appl Pharmacol       Date:  1981-04       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.